These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 5124593)

  • 41. Drug standards in Malaysia.
    Goldstein G
    Med J Aust; 1980 Jan; 1(1):39. PubMed ID: 7360078
    [No Abstract]   [Full Text] [Related]  

  • 42. A perspective on US drug reimportation.
    Choudhry NK; Detsky AS
    JAMA; 2005 Jan; 293(3):358-62. PubMed ID: 15657329
    [No Abstract]   [Full Text] [Related]  

  • 43. Present attitudes of governmental drug regulatory agencies.
    Noel PR
    Int J Clin Pharmacol; 1973 Apr; 7(2):168-77. PubMed ID: 4731283
    [No Abstract]   [Full Text] [Related]  

  • 44. Editorial: The drug makers.
    Med J Aust; 1974 Oct; 2(16):583-4. PubMed ID: 4437418
    [No Abstract]   [Full Text] [Related]  

  • 45. The adverse drug reaction reporting scheme and the Australian drug evaluation committee.
    Walshe AM
    Med J Aust; 1968 Jul; 2(2):82-5. PubMed ID: 5670861
    [No Abstract]   [Full Text] [Related]  

  • 46. Adverse drug reactions--a computer-assisted application of correspondence analysis for automatic causality assessment.
    Bastin C; Wertheimer P; Venulet J
    Methods Inf Med; 1984 Oct; 23(4):183-8. PubMed ID: 6513792
    [No Abstract]   [Full Text] [Related]  

  • 47. Screening criteria for drug monitoring. The Kaiser-Permanente drug reaction monitoring system.
    Friedman GD
    J Chronic Dis; 1972 Jan; 25(1):11-20. PubMed ID: 5027328
    [No Abstract]   [Full Text] [Related]  

  • 48. Drug hepatotoxicity from a regulatory perspective.
    Senior JR
    Clin Liver Dis; 2007 Aug; 11(3):507-24, vi. PubMed ID: 17723917
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experience in monitoring drug reactions in outpatients. The Kaiser-Permanente Drug Monitoring System.
    Friedman GD; Collen MF; Harris LE; Van Brunt EE; Davis LS
    JAMA; 1971 Aug; 217(5):567-72. PubMed ID: 5109088
    [No Abstract]   [Full Text] [Related]  

  • 50. Adverse drug reactions: reducing the burden of treatment.
    Jordan S
    Nurs Stand; 2007 May 2-8; 21(34):35-41. PubMed ID: 17518073
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Computer analysis of epidemiologic data on effect of drugs on hospital patients.
    Slone D; Gaetano LF; Lipworth L; Shapiro S; Lewis GP; Jick H
    Public Health Rep (1896); 1969 Jan; 84(1):39-52. PubMed ID: 4974707
    [No Abstract]   [Full Text] [Related]  

  • 52. A tale of two Es.
    Nutt DJ
    J Psychopharmacol; 2006 May; 20(3):315-7. PubMed ID: 16574702
    [No Abstract]   [Full Text] [Related]  

  • 53. [Active prospective monitoring of pharmacotherapy safety in outpatients: practical value].
    Nazimkin KE; Kukes VG
    Antibiot Khimioter; 2008; 53(11-12):39-43. PubMed ID: 19441657
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Systematic collection of drug side effects].
    May B
    Arzneimittelforschung; 1975 Jul; 25(7a):1215-20. PubMed ID: 1242350
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Frequency of adverse drug reactions.
    DeBoer A
    Br J Clin Pharmacol; 1993 Jul; 36(1):89-91. PubMed ID: 8373719
    [No Abstract]   [Full Text] [Related]  

  • 56. Pattern signalling in health information monitoring systems.
    Levine A; Mandel SP; Santamaria A
    Methods Inf Med; 1977 Jul; 16(3):138-44. PubMed ID: 904476
    [No Abstract]   [Full Text] [Related]  

  • 57. Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: a regulatory perspective.
    Bakke OM; Manocchia M; de Abajo F; Kaitin KI; Lasagna L
    Clin Pharmacol Ther; 1995 Jul; 58(1):108-17. PubMed ID: 7628177
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Events per person year. Can obscure the true risk of certain adverse drug reactions.
    Paterson KR
    BMJ; 1995 Jun; 310(6992):1470. PubMed ID: 7677865
    [No Abstract]   [Full Text] [Related]  

  • 59. [Adverse reactions to drugs in a health center].
    de Frutos Hernansanz MJ; Lázaro Damas A; Llinares Gómez V; Azpiazu Garrido M; Serrano Vázquez A; López de Castro F
    Aten Primaria; 1994 Sep; 14(5):783-6. PubMed ID: 7981380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reliability factors in adverse drug reaction reporting.
    Marlin RL
    Methods Inf Med; 1981 Jul; 20(3):157-62. PubMed ID: 7278693
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.